Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Net Income - Minority for 14 consecutive years, with $336100.0 as the latest value for Q4 2025.

  • Quarterly Net Income - Minority rose 9.29% to $336100.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $336100.0 through Dec 2025, up 9.29% year-over-year, with the annual reading at $336100.0 for FY2025, 9.29% up from the prior year.
  • Net Income - Minority hit $336100.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $307517.0 in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of $336100.0 in Q4 2025 to a low of $139283.0 in Q1 2021.
  • Historically, Net Income - Minority has averaged $231813.0 across 3 years, with a median of $225934.5 in 2021.
  • Biggest five-year swings in Net Income - Minority: skyrocketed 195.44% in 2021 and later grew 9.29% in 2025.
  • Year by year, Net Income - Minority stood at $144352.0 in 2021, then soared by 113.03% to $307517.0 in 2024, then grew by 9.29% to $336100.0 in 2025.
  • Business Quant data shows Net Income - Minority for CPIX at $336100.0 in Q4 2025, $307517.0 in Q4 2024, and $144352.0 in Q2 2021.